Morpholino G(PhAc) subunit
Morpholino G(PhAc) subunit - N (Normal) is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Shipping notes
Shipping notes
Related Products
Specifications
Specifications
-
Catalog No.PR2-051
-
SMILESO=P(N(C)C)(Cl)OCC(CN(C(C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3)C4)OC4N5C(N=C(NC(CC6=CC=CC=C6)=O)NC7=O)=C7N=C5
-
Molecular FormulaC39H39ClN7O5P
-
Molecular Weight752.20
-
AppearanceWhite to yellow powder, free from visible foreign matter
-
PurityHPLC≥98.0%
-
Storage ConditionBelow -40℃
Documentation
Documentation
-
Catalog No.PR2-051
-
SMILESO=P(N(C)C)(Cl)OCC(CN(C(C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3)C4)OC4N5C(N=C(NC(CC6=CC=CC=C6)=O)NC7=O)=C7N=C5
-
Molecular FormulaC39H39ClN7O5P
-
Molecular Weight752.20
-
AppearanceWhite to yellow powder, free from visible foreign matter
-
PurityHPLC≥98.0%
-
Storage ConditionBelow -40℃
Why choose Hongene?
Trusted Partner in Nucleic Acid
Integrated Supply & Commercial Scale
With 26+ years of expertise, we control a secure supply chain for RNA raw materials and provide reliable GMP-grade oligo synthesis from research to commercial kilogram-scale production.
Proprietary Technology & IP
Our proprietary Chemoenzymatic Ligation Platform combines chemical andenzymatic methods, enabling high-putity, cost-effective, and large-scale production of RNA-based therapeutics.
Rigorous Quality
We implement multiple stringent QC steps, maintain ISO certifications, and ensure >99% batch-to-batch consistency, reducing scale-up and PPQ risks.
Manufacturing Scalability
Hongene operates 1.67 million sq. ft Oligonucleotide Manufacturing Facility, with advanced equipments including multiple OligoPilot™ and OligoProcess™ synthesizers (10-1800 mmol). 48 flexible production lines enable one-stop seamless scaling-up of API production from gram-level to tons and acheive high purity of 98%, meeting NMPA, FDA, and EMA standards.
Global Business Network
Our products and services reach over 40 countries and regions, supporting around 3,000 clients worldwide.
